These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32886902)

  • 1. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
    Gerds AT; Gotlib J; Bose P; Deininger MW; Dunbar A; Elshoury A; George TI; Gojo I; Gundabolu K; Hexner E; Hobbs G; Jain T; Jamieson C; Kuykendall AT; McMahon B; Mohan SR; Oehler V; Oh S; Pardanani A; Podoltsev N; Ranheim E; Rein L; Salit R; Snyder DS; Stein BL; Talpaz M; Thota S; Vachhani P; Wadleigh M; Walsh K; Ward DC; Bergman MA; Sundar H
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1248-1269. PubMed ID: 32886902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
    Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A
    Venable ER; Gagnon MF; Pitel BA; Palmer JM; Peterson JF; Baughn LB; Hoppman NL; Greipp PT; Ketterling RP; Patnaik MS; Kelemen K; Xu X
    Cold Spring Harb Mol Case Stud; 2023 Feb; 9(1):. PubMed ID: 36627146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children.
    Berking AC; Flaadt T; Behrens YL; Yoshimi A; Leipold A; Holzer U; Lang P; Quintanilla-Martinez L; Schlegelberger B; Reiter A; Niemeyer C; Strahm B; Göhring G
    Cancer Genet; 2023 Apr; 272-273():29-34. PubMed ID: 36657267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
    Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
    Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
    Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
    Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on eosinophilic disorders.
    Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
    Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
    Saft L; Kvasnicka HM; Boudova L; Gianelli U; Lazzi S; Rozman M
    Histopathology; 2023 Dec; 83(6):829-849. PubMed ID: 37551450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
    Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
    Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
    Savage N; George TI; Gotlib J
    Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA.
    Zanelli M; Smith M; Zizzo M; Carloni A; Valli R; De Marco L; Foroni M; Palicelli A; Martino G; Ascani S
    BMC Pulm Med; 2019 Nov; 19(1):216. PubMed ID: 31744552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
    Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
    Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls.
    Kim AS; Pozdnyakova O
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):643-651. PubMed ID: 35478091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of
    Zhang L; Zhu X; Qu W; Lu Y; Feng Z; Zhao L
    Haematologica; 2023 Dec; 108(12):3506-3510. PubMed ID: 37102606
    [No Abstract]   [Full Text] [Related]  

  • 19. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
    Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
    Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.